References
- Plummer FA, Ball TB, Kimani J, Fowke KR. Resistance to HIV-1 infection among highly exposed sex workers in Nairobi: what mediates protection and why does it develop? Immunol Lett 1999;66:27–34.
- Fowke KR, Dong T, Rowland-Jones SL, Oyugi J, Rutherford WJ, Kimani J, . Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya. Lancet 1996;348:1347–51.
- Almonti JB, Koesters SA, Kimani J, Matu L, Wachihi C, Plummer F, . CD4+ T cell responses in HIV-exposed seronegative women are qualitatively distinct from those in HIV-infected women. J Infect Dis 2005;191:20–4.
- Rowland-Jones SL, Dong T, Fowke KR, Kimani J, Krausa P, Newell H, . Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi. J Clin Invest 1998;102:1758–65.
- Kaul R, Trabattoni D, Bwayo JJ, Arienti D, Zagliani A, Mwangi FM, . HIV-1-specific mucosal IgA in a cohort of HIV-1-resistant Kenyan sex workers. AIDS 1999;13:23–9.
- Trivedi HN, Plummer FA, Anzala AO, Njagi E, Bwayo JJ, Ngugi EN, . Resistance to HIV-1 infection among African sex workers is associated with global hyporesponsiveness in interleukin 4 production. FASEB J 2001;15:1795–7.
- Fowke KR, Dong T, Rowland-Jones SL, Oyugi J, Rutherford WJ, Kimani J, . HIV type 1 resistance in Kenyan sex workers is not associated with altered cellular susceptibility to HIV type 1 infection or enhanced beta-chemokine production. AIDS Res Hum Retroviruses 1998;14:1521–30.
- Dunand VA, Ng CM, Wade JA, Bwayo J, Plummer FA, MacDonald KS. HLA-DR 52- and 51-associated DRB1 alleles in Kenya, East Africa. Tissue Antigens 1997;49:397–402.
- MacDonald KS, Fowke KR, Kimani J, Dunand VA, Nagelkerke NJ, Ball TB, . Influence of HLA supertypes on susceptibility and resistance to human immunodeficiency virus type 1 infection. J Infect Dis 2000;181:1581–9.
- MacDonald KS, Matukas L, Embree JE, Fowke K, Kimani J, Nagelkerke NJ, . Human leucocyte antigen supertypes and immune susceptibility to HIV-1, implications for vaccine design. Immunol Lett 2001;79:151–7.
- Ball TB, Ji H, Kimani J, McLaren P, Marlin C, Hill AV, . Polymorphisms in IRF-1 associated with resistance to HIV-1 infection in highly exposed uninfected Kenyan sex workers. AIDS 2007;21:1091–101.
- Sgarbanti M, Borsetti A, Moscufo N, Bellocchi MC, Ridolfi B, Nappi F, . Modulation of human immunodeficiency virus 1 replication by interferon regulatory factors. J Exp Med 2002;195:1359–70.
- Sgarbanti M, Remoli AL, Marsili G, Ridolfi B, Borsetti A, Perrotti E, . IRF-1 is required for full NF-kappaB transcriptional activity at the human immunodeficiency virus type 1 long terminal repeat enhancer. J Virol 2008;82:3632–41.
- Ao Z, Fowke KR, Cohen EA, Yao X. Contribution of the C-terminal tri-lysine regions of human immunodeficiency virus type 1 integrase for efficient reverse transcription and viral DNA nuclear import. Retrovirology 2005, 2:62.
- Yao XJ, Subbramanian RA, Rougeau N, Boisvert F, Bergeron D, Cohen EA. Mutagenic analysis of human immunodeficiency virus type 1 Vpr: role of a predicted N-terminal alpha-helical structure in Vpr nuclear localization and virion incorporation. J Virol 1995;69:7032–44.
- Yao XJ, Kobinger G, Dandache S, Rougeau N, Cohen E. HIV-1 Vpr-chloramphenicol acetyltransferase fusion proteins: sequence requirement for virion incorporation and analysis of antiviral effect. Gene Ther 1999, 6:1590–9.
- Mamane Y, Heylbroeck C, Genin P, Algarte M, Servant MJ, LePage C, . Interferon regulatory factors: the next generation. Gene 1999, 237:1–14.
- Kroger A, Koster M, Schroeder K, Hauser H, Mueller PP. Activities of IRF-1. J Interferon Cytokine Res 2002, 22:5–14.
- Bartz SR, Rogel ME, Emerman M. Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control. J Virol 1996, 70:2324–31.